StockData

Elanco Animal Health vs Phibro Animal Health

ELAN and PAHC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ELAN and PAHC compare

Elanco Animal Health is the larger company, worth 9.1 times as much as Phibro Animal Health ($12.9B against $1.4B).

Phibro Animal Health grew revenue faster over the last twelve months (17.1% versus 12.0% for Elanco Animal Health).

Phibro Animal Health keeps more of each dollar of sales as profit, with a net margin of 6.6% compared with −4.0% at Elanco Animal Health.

Phibro Animal Health pays a dividend yielding 1.4%; Elanco Animal Health does not pay one.

Phibro Animal Health scores higher on the StockData Score (22 against 9 for Elanco Animal Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricELANPAHC
Size and price
Market cap$12.9B$1.4B
Share price$25.85$34.92
Change, 1 year22.6%−22.6%
Change, 5 years−14.5%67.2%
Beta (5Y)0.12−0.07
Employees9,4002,605
StockData Score
Total score922 (better)
Valuation score15 (better)
Growth score36 (better)
Performance score36 (better)
Health score22
Dividend score03 (better)
Valuation
P/E–14.4×
P/S2.6×0.9× (better)
P/B2.0× (better)3.7×
EV/EBITDA30.9×5.4× (better)
P/FCF34.1× (better)144×
PEG–0.32
FCF yield2.9% (better)0.70%
Fair value$11.31$65.12
Margin of safety−129%46.4% (better)
Growth
Revenue growth (TTM)12.0%17.1% (better)
Revenue growth, 5Y average7.6%12.7% (better)
Net income growth (TTM)−146%107% (better)
EPS growth (TTM)−149%104% (better)
EPS growth, 5Y average–12.6%
Profitability
Gross margin55.4% (better)33.8%
Operating margin–12.8%
Net margin−4.0%6.6% (better)
FCF margin7.5% (better)0.65%
Return on equity−3.0%29.7% (better)
Return on invested capital–24.7%
Financial health
Debt / equity0.59–
Net debt / EBITDA6.43–
Interest coverage–4.2×
Current ratio2.052.96 (better)
Altman Z-score1.443.02 (better)
Piotroski F-score66
Dividends and buybacks
Dividend yield–1.4%
Payout ratio–19.5%
Years of dividend growth–0
Dividend growth, 5Y average–0.00%
Shareholder yield0.00%1.4% (better)
Ownership
Held by institutions113%51.8%
Held by insiders1.1%98.9%
Insider net buying, 12 months$2.5M (better)−$23.0M
Short interest, % of float6.7%233%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.